Shang-Hung Chang Selected Research

N(4)-oleylcytosine arabinoside

1/2022	Major Bleeding Risk in Atrial Fibrillation Patients Co-Medicated With Non-Vitamin K Oral Anticoagulants and Antipsychotics.
10/2021	Clinical Outcomes in Atrial Fibrillation Patients With a History of Cancer Treated With Non-Vitamin K Antagonist Oral Anticoagulants: A Nationwide Cohort Study.
1/2021	Comparison Between Non-vitamin K Antagonist Oral Anticoagulants and Low-Molecular-Weight Heparin in Asian Individuals With Cancer-Associated Venous Thromboembolism.
1/2021	Incidence and consequences of resuming oral anticoagulant therapy following hematuria and risks of ischemic stroke and major bleeding in patients with atrial fibrillation.
10/2020	Novel oral anticoagulant vs. warfarin in elderly atrial fibrillation patients with normal, mid-range, and reduced left ventricular ejection fraction.
1/2020	Efficacy and safety of NOAC versus warfarin in AF patients with left atrial enlargement.
1/2020	Novel Oral Anticoagulant versus Warfarin in Cancer Patients with Atrial Fibrillation: An 8-Year Population-Based Cohort Study.
1/2020	Effectiveness, safety, and major adverse limb events in atrial fibrillation patients with concomitant diabetes mellitus treated with non-vitamin K antagonist oral anticoagulants.
1/2020	Assessing major bleeding risk in atrial fibrillation patients concurrently taking non-vitamin K antagonist oral anticoagulants and antiepileptic drugs.
11/2019	Efficacy and Safety of Oral Anticoagulants in Patients With Atrial Fibrillation and Stages 4 or 5 Chronic Kidney Disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shang-Hung Chang Research Topics

Disease

44	Atrial Fibrillation 10/2022 - 04/2014
43	Hemorrhage 10/2022 - 01/2014
23	Ischemic Stroke 10/2022 - 01/2016
21	Stroke (Strokes) 01/2022 - 01/2016
20	Myocardial Infarction 10/2022 - 01/2008
18	Embolism (Embolus) 01/2022 - 01/2016
13	Heart Failure 01/2022 - 01/2012
12	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 01/2013
12	Chronic Renal Insufficiency 10/2021 - 11/2016
9	Thromboembolism 01/2021 - 01/2018
8	Type 2 Diabetes Mellitus (MODY) 10/2021 - 08/2014
8	Thrombosis (Thrombus) 03/2020 - 01/2012
7	Wounds and Injuries (Trauma) 01/2022 - 03/2014
7	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2022 - 01/2016
7	Hyperplasia 01/2019 - 01/2014
6	Neoplasms (Cancer) 04/2022 - 01/2019
6	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 01/2014
5	Diabetes Mellitus 01/2021 - 11/2016
4	Chronic Kidney Failure (Chronic Renal Failure) 10/2021 - 04/2014
4	Liver Cirrhosis (Hepatic Cirrhosis) 10/2020 - 01/2019
4	Hypertension (High Blood Pressure) 09/2020 - 11/2016
4	Death (Near-Death Experience) 07/2017 - 11/2012
4	Atherosclerosis 07/2017 - 04/2012
4	ST Elevation Myocardial Infarction 05/2016 - 11/2012
3	Transient Ischemic Attack 10/2022 - 11/2016
3	Coronary Stenosis (Coronary Artery Stenosis) 01/2022 - 04/2004
3	Fibrosis (Cirrhosis) 01/2022 - 01/2017
3	Chronic Limb-Threatening Ischemia 01/2021 - 04/2014
3	Peripheral Arterial Disease 01/2021 - 01/2020
3	Aortic Dissection 01/2021 - 05/2016
3	Acute Kidney Injury (Acute Renal Failure) 01/2020 - 11/2016
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2019 - 03/2017
3	Vascular Diseases (Vascular Disease) 01/2019 - 11/2016
2	Thrombocytopenia (Thrombopenia) 01/2022 - 05/2019
2	Gastrointestinal Hemorrhage (Hematochezia) 01/2022 - 01/2018
2	Infections 01/2022 - 01/2021
2	Anemia 01/2022 - 01/2019
2	Peptic Ulcer (Peptic Ulcers) 01/2021 - 01/2019
2	Sepsis (Septicemia) 01/2021 - 01/2020
2	Insulin Resistance 01/2019 - 01/2018
2	Pathologic Constriction (Stenosis) 05/2018 - 04/2004
2	Vascular System Injuries 01/2018 - 08/2017
2	Intracranial Embolism 01/2018 - 01/2016
2	Acute Coronary Syndrome 01/2015 - 01/2015
2	Inflammation (Inflammations) 01/2014 - 01/2013

Drug/Important Bio-Agent (IBA)

36	AnticoagulantsIBA 04/2022 - 01/2016
31	Warfarin (Coumadin)FDA LinkGeneric 01/2022 - 01/2016
17	Vitamin K FDA Link 01/2022 - 01/2016
15	N(4)-oleylcytosine arabinosideIBA 01/2022 - 10/2017
12	omega-Chloroacetophenone (Mace)IBA 01/2022 - 01/2013
12	Dabigatran FDA Link 10/2021 - 01/2016
11	RivaroxabanIBA 10/2021 - 01/2016
8	apixabanIBA 01/2022 - 10/2017
7	Pharmaceutical PreparationsIBA 01/2021 - 01/2014
6	MetalsIBA 05/2018 - 01/2016
5	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 04/2016
5	Metformin (Glucophage)FDA LinkGeneric 09/2020 - 03/2014
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2021 - 01/2014
4	Angiotensin Receptor AntagonistsIBA 01/2021 - 04/2016
3	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 10/2022 - 01/2019
3	Insulin (Novolin)FDA Link 01/2021 - 01/2020
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2021 - 11/2017
3	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 04/2013
3	CollagenIBA 01/2017 - 01/2015
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 04/2022 - 10/2017
2	Hemoglobins (Hemoglobin)IBA 01/2022 - 01/2019
2	Sodium-Glucose Transport ProteinsIBA 10/2021 - 01/2020
2	edoxabanIBA 10/2021 - 01/2019
2	Allopurinol (Remid)FDA LinkGeneric 01/2021 - 01/2020
2	Febuxostat FDA Link 01/2021 - 01/2020
2	Clopidogrel (Plavix)FDA Link 01/2021 - 01/2012
2	Platelet-Derived Growth FactorIBA 10/2020 - 11/2015
2	poly(lactide) (polylactic acid)IBA 01/2020 - 02/2015
2	Phenytoin (Dilantin)FDA LinkGeneric 01/2020 - 10/2017
2	Phenobarbital (Luminal)FDA Link 01/2020 - 04/2004
2	Amiodarone (Amiodarona)FDA LinkGeneric 10/2017 - 01/2008
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2017 - 01/2015
2	AutoantibodiesIBA 02/2016 - 04/2012
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 11/2015 - 02/2015
1	bicalutamide (Casodex)FDA LinkGeneric 04/2022
1	nilotinib FDA Link 04/2022
1	Cytochrome P-450 CYP3AIBA 04/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2022
1	Anastrozole (Arimidex)FDA LinkGeneric 04/2022
1	Vinorelbine (Navelbine)FDA LinkGeneric 04/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2022
1	abirateroneIBA 04/2022
1	Etoposide (VP 16)FDA LinkGeneric 04/2022
1	Methotrexate (Mexate)FDA LinkGeneric 04/2022
1	Imatinib Mesylate (Gleevec)FDA Link 04/2022
1	Irinotecan (Camptosar)FDA LinkGeneric 04/2022
1	Docetaxel (Taxotere)FDA Link 04/2022

Therapy/Procedure

21	Stents 10/2022 - 01/2012
19	Therapeutics 10/2022 - 01/2008
6	Percutaneous Coronary Intervention 01/2022 - 01/2012
6	Drug-Eluting Stents 02/2019 - 11/2012
4	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2022 - 02/2014
3	Surgical Amputation (Amputations) 01/2021 - 04/2014
3	Extracorporeal Membrane Oxygenation 11/2020 - 01/2020
2	Blood Transfusion (Blood Transfusions) 01/2021 - 01/2020